Title:
エストラ−1,3,5(10),16−テトラエン−3−カルボキサミド誘導体、それらの製造方法、それらを含む医薬製剤および医薬を製造するためのそれらの使用
Document Type and Number:
Japanese Patent JP5791810
Kind Code:
B2
Abstract:
The invention relates to AKR1C3 inhibitors and to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular bleeding disorders and endometriosis.
More Like This:
Inventors:
Ulrich Bothe
Naomi Barack
Matthias Bouzemann
Oliver Martin Fisher
Andrea Rothgeri
Isabella Gashav
Ingo Hartung
Tobias Markwald
Naomi Barack
Matthias Bouzemann
Oliver Martin Fisher
Andrea Rothgeri
Isabella Gashav
Ingo Hartung
Tobias Markwald
Application Number:
JP2014532337A
Publication Date:
October 07, 2015
Filing Date:
September 24, 2012
Export Citation:
Assignee:
Bayer Intellectual Property GmbH
International Classes:
C07J43/00; A61K31/58; A61K45/00; A61P3/04; A61P11/00; A61P13/08; A61P15/00; A61P15/08; A61P17/08; A61P17/10; A61P17/14; A61P25/04; A61P29/00; A61P35/00; A61P43/00
Domestic Patent References:
JP7505377A |
Foreign References:
WO2008065100A1 | ||||
WO2005089256A2 | ||||
US6541463 |
Other References:
ACS P. et al.,Steroids,2011年,Vol.76,p.280-90
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe